<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comentários em: Programa XANTUS da Bayer confirma taxas reduzidas de hemorragia e AVC em mais de 11 mil doentes com fibrilhação auricular tratados com rivaroxabano	</title>
	<atom:link href="https://newsfarma.pt/noticias/programa-xantus-da-bayer-confirma-taxas-reduzidas-de-hemorragia-e-avc-em-mais-de-11-mil-doentes-com-fibrilhacao-auricular-tratados-com-rivaroxabano/feed/" rel="self" type="application/rss+xml" />
	<link>https://newsfarma.pt/noticias/programa-xantus-da-bayer-confirma-taxas-reduzidas-de-hemorragia-e-avc-em-mais-de-11-mil-doentes-com-fibrilhacao-auricular-tratados-com-rivaroxabano/</link>
	<description>Comunicamos Saúde.</description>
	<lastBuildDate>Thu, 12 Jul 2018 14:05:52 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
</channel>
</rss>
